Ratings Summary for REGLAN

Overall Patient opinion of REGLAN: 1.4 (extremely dissatisfied)

(based on 655 reviews ) (updated May 6, 2025)

Ratings by Age Group for REGLAN
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)	27	1.2
Age 18 to 24	77	1.2
Age 25 to 34	176	1.2
Age 35 to 44	153	1.5
Age 45 to 54	94	1.7
Age 55 to 64	66	1.3
Age 65 to 74	31	1.3
Age 75 and up	11	1

Ratings by Sex for REGLAN
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	144	1.5
Female	500	1.396
Not Specified	8	2

Would you like to find reviews for REGLAN taken for a specific reason or resulting in a specific side effect?

Filter Results for REGLAN

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for REGLAN

Check here for Ask a Patient's Adverse Event Summary for REGLAN based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

REGLAN (METOCLOPRAMIDE HYDROCHLORIDE): This medication is used to treat certain conditions of the stomach and intestines. Metoclopramide is used as a short-term treatment (4 to 12 weeks) for persistent heartburn when the usual medicines do not work well enough. It is used mostly for heartburn that occurs after a meal or during the daytime. Treating persistent heartburn can decrease the damage done by stomach acid to the swallowing tube (esophagus) and help healing. Metoclopramide is also used in diabetic patients who have poor emptying of their stomachs (gastroparesis). Treating gastroparesis can decrease symptoms of nausea, vomiting, and stomach/abdominal fullness. Metoclopramide works by blocking a natural substance (dopamine). It speeds up stomach emptying and movement of the upper intestines. This drug is not recommended for use in children due to an increased risk of serious side effects (such as muscle spasms/uncontrolled muscle movements). Ask the doctor or pharmacist for details. FDA Approval Date: (Sources: U.S. Centers for Medicare Services, FDA)